Abiopharma

The CLAL INSURANCE ENTERPRISES HOLDINGS LTD Periodic Report for 2025- translated version [The Hebrew periodic report was published on March 26, 2026]

Lumen Technologies, Inc. Announces Offering of Senior Notes Due 2037 and Concurrent Tender Offers

InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases

InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases

SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

Agilysys Unveils Over 30 New AI-Powered Features and Software Modules at INSPIRE Technology User Conference 2026

VolitionRx Announces Submission of Manuscript forNu.Q® Vet Cancer Test in Cats

Accenture Invests in XBOW to Advance Continuous Offensive Security Testing and Exposure Management

Net Asset Value(s)

Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection